A number of European studies have documented the ability of procalcitonin (PCT), a novel inflammatory marker, to discriminate patients with sepsis from those with other causes of systemic inflammatory response syndrome (SIRS). The aim of this study was to assess procalcitonin's performance in an Australian intensive care unit (ICU) setting to examine whether it could discriminate between these two conditions.
Critically ill patients will often manifest a systemic inflammatory response syndrome (SIRS) in the absence of an infection 1 . The objective parameters of infection (such as temperature and white cell count) lack sensitivity and specificity and overlap with diagnostic criteria for SIRS. Microbiological culture takes at least 24 hours and though more specific, lacks sensitivity. Early identification of septic patients is crucial to management and outcome [1] [2] [3] [4] as sepsis is the most common cause of death in the intensive care setting 5, 6 . Conversely, overutilization of antibiotics can lead to emergence of multiresistant organisms, increased toxicity and increased cost 7, 8 .
Procalcitonin, a 116-amino acid precursor of calcitonin, has been shown to be raised in a number of non thyroidal disorders without elevation of the mature calcitonin. Concentrations are very low in healthy volunteers 9,10 but elevated in a number of infectious 11, 12 and non-infectious 13, 14 disease states. There is mounting evidence that PCT is a useful marker in discriminating sepsis from non-infectious SIRS 10, 13, 14, 15 . The advantage of PCT as a biological marker of sepsis is that it appears to be specific for infection or for infection inducing organ dysfunction whilst other proteins that have been studied such as CRP, neopterin, cytokines and chemokines are not specific 16 .
We undertook a validation study of PCT to assess its performance in discriminating infectious SIRS 1 from non-infectious SIRS in an Australian ICU setting.
PATIENTS AND METHODS
One hundred and twenty-three consecutive adult ICU patients fulfilling established criteria for SIRS 1 were included in the study. Residual serum from the routine CRP measurements or plasma from the ethylene-diamine-tetra-acetic acid (EDTA) tubes used for routine full blood counts were used to measure PCT.
Daily PCT and CRP concentrations were determined on serum or plasma samples over a five-day period starting on the day of entry into the study. The PCT values were not available to the ICU physicians.
Blood, urine (midstream or catheter urine) and respiratory (sputum or broncho-alveolar lavage) cultures were obtained on day one of recruitment to the study and again on day four. Other cultures were performed as clinically indicated (including central venous catheters and cerebrospinal fluid). Infection was defined as a positive result with at least one culture of a recognised human pathogen.
Senior ICU registrars blinded to PCT results completed a questionnaire (Table 1) on each patient at day one and day four to define clinical suspicion of bacterial sepsis. The criteria used to diagnose clinical infection were fever, elevated or depressed white cell count, hypotension, likely site of infection and positive microbiological cultures. This questionnaire was then reviewed by the registrar involved in the study and the patients were assigned to the clinical infection or non-infection groups. Patients were grouped as non-infectious SIRS if there was a low clinical suspicion of bacterial infection on both day one and day four and all culture results were negative.
Other data were collected by chart review and included demographics (age and gender), APACHE II score, length of stay in hospital and in ICU, as well as death before discharge ( Table 2) .
Mann-Whitney Tests were used to assess the significance of differences in maximum PCT and CRP between different subgroups of categorical variables. Spearman rank correlations were used to quantify the association between maximum PCT, CRP and other continuous variables. Logistic regression analysis was performed for blood culture status with respect to maximum PCT and APACHE II. Receiver operating characteristics (ROC) curves and areas under the curves (AUC) were calculated.
RESULTS
Summary statistics for maximum PCT and maxi- Tables 3 and 4 . Because of the skewed nature of the data, median values with lower and upper quartiles were used instead of means with standard deviations.
The Mann-Whitney test revealed a significant difference in maximum PCT between those who died in hospital and those who did not (P=0.003). Patients with positive blood cultures had maximum PCT values ten times higher than those with sterile blood cultures (P<0.001).
Significant differences in maximum CRP were also found with positive blood cultures (P=0.005) and death occurring in hospital (P=0.003). CRP values of patients with positive blood cultures were nearly double those with sterile blood cultures.
The maximum PCT value occurred with bacteraemia/septicaemia and fell within 24 hours of the introduction of the appropriate antibiotics. The CRP value was slower to fall.
There were no significant differences in maximum PCT or maximum CRP between male and female gender, or between those in the non-infectious SIRS group and all other patients. No significant differences in maximum PCT or maximum CRP were seen between patients with positive sputum, urine, intra-vascular line or miscellaneous cultures and patients with negative cultures. No significant difference was seen with either marker and the presence or absence of a positive culture of any kind overall.
The maximum PCT value displayed a strong correlation with maximum CRP, older age, and APACHE II score. The maximum CRP value was significantly correlated with maximum PCT and older age.
To assess the ability of PCT to independently predict blood culture status, logistic regression analysis was performed with maximum PCT and APACHE II score (low numbers in the positive blood culture group precluded more extensive analysis with other variables). All patients with negative blood cultures formed one group (regardless of what their sepsis status was thought to be clinically or the presence of positive cultures elsewhere). Those with positive blood cultures formed the other group. After controlling for APACHE II score, PCT remained a significant predictor of blood culture positivity (Odds Ratio/unit increase 1.01, 95% CI 1.005-1.02, P=0.002). However, after controlling for PCT, APACHE II score was no longer significantly associated with blood culture status (Odds Ratio/unit increase 1.04, 95% CI 0.95-1.13, P=0.4)
The white cell count as measured from day 1 to day 7 was not predictive of bacteraemia or death in hospital.
To estimate possible cut-off values for PCT and CRP in terms of sensitivity and specificity, ROC curves were created. This was used firstly to look at the accuracy of the markers for the presence of any bacterial infection within the SIRS population. Those with any positive culture result made up the infected were not significantly different from that of the null hypothesis (0.50). Thus neither inflammatory marker displayed discriminative ability for bacterial infection overall (Figure 1 ). ROC curves were then created for the bacteraemia positive group (n=12) versus the non-infectious SIRS group (n=21) (again those excluded did not differ in terms of other variables from those included) ( Figure 2 ). AUC for PCT was 0.80 (P=0.004) and for CRP was 0.82 (P=0.002), thus demonstrating both markers to have good discriminative ability. An ROC curve for PCT constructed without exclusion of any patients (with all patients without a positive blood culture forming the negative group, and those with a positive blood culture the positive group) resulted in a similar area under the curve (0.81).
Using these curves, different cut-off points were evaluated for sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) ( Table 6 ). Given the inherent trade-off between sensitivity and specificity, different cut-off values for the inflammatory markers can be chosen depending on whether it is to be used as a screening test to rule out sepsis (with a high sensitivity and NPV) or as a diagnostic test (with high specificity and PPV). Used as a screening test, a cut-off point of 185 mg/l for CRP was 83% sensitive, while retaining a specificity of 76% (NPV of 89% and PPV of 67%). A value ≥3.03 ng/ml for PCT on the other hand also had a sensitivity of 83%, but specificity was 48% (NPV 83% and PPV 50%). Using both markers with either CRP ≥185 mg/l or PCT ≥3.03 ng/ml resulted in 100% sensitivity, specificity of 43%, NPV 100% and PPV 50%. At the other end of the spectrum, using PCT ≥15.75 ng/ml, a specificity of 91% and sensitivity of 75% was calculated (NPV 86%, PPV 83%). Combining both markers with PCT ≥15.75 ng/ml and CRP ( 185 mg/l, the specificity rose to 95%, with a sensitivity of 58% (NPV 80%, PPV 88%).
DISCUSSION
Studies of patients with SIRS have produced differing results as to whether PCT is useful in discriminating infection from other causes of the syndrome [9] [10] [11] [13] [14] [15] [16] [17] [18] [19] [20] [21] .
One possible source of error is that PCT levels rapidly normalize after the administration of antibiotics 9 . Thus partially treated septic patients are not identified, increasing the rate of false negatives in a study. Also, some patients' PCT levels do not peak until day 2 or 3 after developing sepsis 9 . In order to avoid these problems, we measured PCT values from the first day the patient fulfilled criteria for SIRS. The maximum value obtained for the patient over the five-day study period became the summary PCT value assessed as significant for that patient.
Another source of error in previous studies of sepsis and SIRS is the lack of definitive reference standards of diagnosis. There is a subjective element to both the diagnosis of sepsis (clinical suspicion+ positive cultures+SIRS) and non-infectious SIRS (low clinical suspicion of infection+negative cultures +SIRS). The inaccuracy of these classifications would be expected to diminish differences between the two groups; thus the magnitude of any difference found is likely to be a conservative estimate of the true difference.
Categorizing infection of patients into proven, possible and absent has been recommended in studies of sepsis 22 . In the "possibly infected" (clinically thought to have bacteraemia but culture negative) group, it was impossible to assign patients to either the definitely infected group or to the non-infected group. Members of this group did not differ in other variables from those in which the diagnosis was defined (i.e. proven infection or absence of infection). The area under the PCT ROC curve for bacteraemia versus non-bacteraemia was the same whether these patients were included (in the nonbacteraemic group) or excluded. Inclusion of all patients without a positive blood culture in the negative group (including those thought to be septic clinically and with positive cultures elsewhere), would be expected to yield results that are a conservative estimate of the true ability of PCT in predicting bacteraemia.
Positive laboratory microbiology may occur in four general settings in the ICU. There may be colonization (positive culture of an organism that is not causing disease), local infection without systemic effects, local infection with systemic effects (no bacteraemia) and systemic infection (with bacteraemia). Both of the last two scenarios are included in the syndrome of sepsis.
In agreement with some studies 11, 19, 22, 23 but in disagreement with others 9,10,13-15 , we did not find either PCT or CRP to be useful markers in the prediction of positive laboratory microbiology overall in patients with SIRS. However, we did find that both PCT and CRP were useful markers for predicting bacteraemia in this population. These findings are in contrast to a previous study of bacteraemia 19 . Median values of PCT in patients with positive blood cultures were ten times that of all other patients. CRP appeared to have slightly greater sensitivity, while PCT was more specific. We found that by using the two tests on an "either or" basis, we were able to create a screening test with 100% sensitivity, 43% specificity, 100% NPV and 50% PPV. As a diagnostic test, PCT was the superior marker; using 15.75 ng/ml as the cut-off, it had specificity of 91%, sensitivity of 75%, PPV of 83% and NPV of 86%.
These results are likely to be an under-estimation of the difference, given that a substantial number of those with negative culture results are likely to truly have been bacteraemic given the low sensitivity of blood cultures 24, 25 . The lack of significant results for other positive cultures may reflect the higher specificity of bacteraemia for sepsis. Culture of other body fluids may yield bacteria because of colonization and localised infection as well as sepsis.
Both markers appear to have prognostic value, with higher median values for those patients who died, and significant rank correlation only between PCT and APACHE II score. APACHE II score was also associated with age, which probably partly accounts for the correlation of PCT and CRP with increasing age.
PCT together with CRP appears to be a marker of bacteraemia and sepsis in the ICU. What advantages does its measurement bring to the clinician in determining management of the SIRS patient? It has been said that PCT does not aid in the diagnosis of sepsis as it merely identifies the more severely affected patients (those in septic shock), i.e. patients who can be diagnosed clinically 20 . However in our study, PCT remained a predictor of blood culture status after controlling for APACHE II score, whereas the reverse was not true. This argues that PCT can identify bacteraemic patients additional to those apparent clinically (with high APACHE II scores).
PCT was able to identify all the patients who had positive blood cultures in our study. Within the large group of patients where the laboratory microbiological status was not able to be defined, there were many that would also be diagnosed as "probable sepsis" patients based on their PCT and CRP values. While these inflammatory markers should not and could not replace microbiological culture, their measurement may provide a more sensitive tool for the identification of bacteraemic (and septic) patients than tests currently in use. The tests have the added advantage of a more rapid turnaround time, with results within a few hours (as opposed to at least a two day delay for culture results). As a screening test, PCT and CRP could be used to direct the clinician to those patients more likely to be septic and where bacteriological culture should be performed. Thus in the ICU setting PCT measurement would be best done in patients who were thought to have systemic bacterial sepsis 21 . Used as a diagnostic test, PCT values over a certain range (15 ng/ml in our study, but 10 ng/ml in other studies overseas) 9 should prompt the clinician to search extensively for a source of sepsis and institute appropriate antibiotic treatment. Persistently high PCT values should alert the clinician to the possibility of failure of current treatment regimens, prompting them to consider alternative therapy (such as changing antibiotics) as well as to instigate a renewed search for a microbiological source of the infection.
Based on the evidence of our study, we believe PCT has a role in the ICU setting. We have outlined some of the ways we envisage PCT (with or without CRP) could be used within the ICU. We believe the novel marker provides a useful tool in the diagnostic work-up of the SIRS/septic patient, adding to the clinician's current diagnostic armamentarium of clinical history and exam, physiological measurements and microbiological culture.
Future studies should define whether the measurement of PCT and or CRP can influence antibiotic usage in the ICU setting. Further studies in the Emergency Room setting may also lead to more efficient triaging of ill patients.
